Chronic kidney disease (CKD) is a progressive condition in dogs causing nausea, lethargy, and eventual uraemic crisis, requiring careful monitoring and staging to optimise quality of life for as long as possible.
Chronic kidney disease creates a long-term welfare management challenge that requires sustained owner commitment and regular veterinary partnership. The insidious nature of CKD means dogs often present with advanced disease because early signs — subtle increased thirst and urination — are easily missed or attributed to aging. By the time uraemic signs (vomiting, mouth ulcers, weight loss) appear, significant nephron loss has occurred. Good welfare management begins with early detection through annual SDMA screening in at-risk older dogs, allowing dietary modification before clinical signs develop. Phosphate restriction slows progression and is achievable through prescription renal diets that are palatable to most dogs. The welfare trade-off in late-stage disease involves balancing the discomfort of hospitalised fluid therapy against the benefit of managing uraemia — home subcutaneous fluid administration avoids hospitalisation stress while achieving similar fluid benefits. Quality-of-life assessment using owner-reported scales helps guide decisions about intensifying versus withdrawing treatment as disease progresses.